Abstract
This report demonstrates a late presenter and long-term survivor (38 months old) of alveolar capillary dysplasia with misalignment of the pulmonary veins (ACD/MPV) and with a heterozygous frameshift mutation in FOXF1. The mild phenotype may be due to his residual normal lung tissue as demonstrated in the chest computed tomography (CT) and histopathological findings.
Conclusion: We report the longest survivor of ACD/MPV. The mild phenotype is most likely due to the patient’s residual normal lung tissue.
What is Known: • Patients with ACD/MPV uniformly die early in life. • A previously reported case with the same mutation in FOXF1 died at 15 days after birth. |
What is New: • The presented case is the longest survivor with this disease. • The patient’s mild phenotype can be explained by his residual normal lung tissue. |
Similar content being viewed by others
Abbreviations
- ACD/MPV:
-
Alveolar capillary dysplasia with misalignment of the pulmonary veins
- CT:
-
Computed tomography
- NO:
-
Nitric oxide
- PCR:
-
Polymerase chain reaction
References
Abdallah HI, Karmazin N, Marks LA (1993) Late presentation of misalignment of lung vessels with alveolar capillary dysplasia. Crit Care Med 21:628–630
Ahmed S, Ackerman V, Faught P, Langston C (2008) Profound hypoxemia and pulmonary hypertension in a 7-month-old infant: late presentation of alveolar capillary dysplasia. Pediatr Crit Care Med 9:e43–e46
Bishop NB, Stankiewicz P, Steinhorn RH (2011) Alveolar capillary dysplasia. Am J Respir Crit Care Med 184:172–179
Boggs S, Harris MC, Hoffman DJ, Goel R, McDonald-McGinn D, Langston C, Zackai E, Ruchelli E (1994) Misalignment of pulmonary veins with alveolar capillary dysplasia: affected siblings and variable phenotypic expression. J Pediatr 124:125–128
Kodama Y, Tao K, Ishida F, Kawakami T, Tsuchiya K, Ishida K, Takemura T, Nakazawa A, Matsuoka K, Yoda H (2012) Long survival of congenital alveolar capillary dysplasia patient with NO inhalation and epoprostenol: effect of sildenafil, beraprost and bosentan. Pediatr Int 54:923–926
Sato M, Okada Y, Oto T, Minami M, Shiraishi T, Nagayasu T, Yoshino I, Chida M, Okumura M, Date H, Miyoshi S, Kondo T (2014) Registry of the Japanese Society of Lung and Heart-Lung Transplantation: official Japanese lung transplantation report, 2014. Gen Thorac Cardiovasc Surg 62:594–601
Sen P, Yang Y, Navarro C, Silva I et al (2013) Novel FOXF1 mutations in sporadic and familial cases of alveolar capillary dysplasia with misaligned pulmonary veins imply a role for its DNA binding domain. Hum Mutat 34:801–811
Shankar V, Haque A, Johnson J, Pietsch J (2006) Late presentation of alveolar capillary dysplasia in an infant. Pediatr Crit Care Med 7:177–179
Stankiewicz P, Sen P, Bhatt SS et al (2009) Genomic and genic deletions of the FOX gene cluster on 16q24.1 and inactivating mutations of FOXF1 cause alveolar capillary dysplasia and other malformations. Am J Hum Genet 84:780–791
Szafranski P, Dharmadhikari AV, Brosens E et al (2013) Small noncoding differentially methylated copy-number variants, including lncRNA genes, cause a lethal lung developmental disorder. Genome Res 23:23–33
Acknowledgments
We thank Dr. Christine Kwan for editing and revising this manuscript.
Conflict of interest
The authors declare no conflict of interest.
Authors’ contribution
YI, TD, SK, and YK treated the patient (YI wrote the manuscript under SK’s supervision, and YK took all responsibility of the therapy). MT and MK made the diagnosis using biopsy samples, and TA identified the FOXF1 mutation. KC and MY were consulted about the patient.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by Beat Steinmann
Rights and permissions
About this article
Cite this article
Ito, Y., Akimoto, T., Cho, K. et al. A late presenter and long-term survivor of alveolar capillary dysplasia with misalignment of the pulmonary veins. Eur J Pediatr 174, 1123–1126 (2015). https://doi.org/10.1007/s00431-015-2543-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-015-2543-3